Lumos Pharma

-$0.07 (-0.76%) Today
+$0.15 (+1.63%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Lumos Pharma and other ETFs, options, and stocks.

About LUMO

Lumos Pharma, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics for rare diseases. Its product includes LUM-201, an oral growth hormone stimulating small molecule for the treatment of pediatric growth hormone deficiency (PGHD).

CEO
Richard J. Hawkins
Employees
28
Headquarters
Austin, Texas
Founded
1999

LUMO Key Statistics

Market Cap
76.72M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
8.99K
High Today
$9.46
Low Today
$9.08
Open Price
$9.14
Volume
16.50K
52 Week High
$36.72
52 Week Low
$7.23

LUMO Earnings

-$1.04
-$0.62
-$0.21
$0.21
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 4
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure